Latest filing published 31 Oct 2013 for Arno Therapeutics, Inc.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by William F. Hamilton PhD span 3 companies, the busiest being Novadel Pharma Inc, Arno Therapeutics, Inc and Neose Technologies Inc. In total, 5 filings cover trades dated from 28 August 2007 to 29 October 2013.
The open-market record is one-sided, with 4 purchases worth €4,832 and not one sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise. So far in 2013, the count stands at 1 purchase and no sales.
Half of the purchases are above €2,346 and half below.
Most recently, on 31 October 2013, the filings show an open-market purchase in Arno Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations